BACKGROUND: Little data are available on bacterial contamination (BC) of platelet units or acute transfusion reactions to platelet transfusions (PTs) in sub-Saharan Africa (SSA). STUDY DESIGN AND METHODS: This prospective, observational study evaluated the rate of BC in whole blood-derived platelet units (WB-PUs), the utility of performing Gram stains to prevent septic reactions, characteristics of patients receiving PTs, and the rate of acute reactions associated with PTs at the Uganda Cancer Institute in Kampala, Uganda. An aliquot of each WB-PU studied was taken to perform Gram stains and culture using the Bactec 9120 instrument. Study participants were monitored for reactions. RESULTS: In total, 337 WB-PUs were evaluated for BC, of which 323 units were transfused in 151 transfusion episodes to 50 patients. The frequency of BC ranged from 0.3% to 2.1% (according to criteria used to define BC). The Gram stain had high specificity (99.1%) but low sensitivity to detect units with BC. The median platelet count before PT was 10,900 cells/µL (interquartile range, 6000-18,900 cells/µL). Overall, 78% of PTs were given to patients with no bleeding. Acute reactions occurred in 11 transfusion episodes, involving 13 WB-PUs, for a rate of 7.3% (95% confidence interval, 3.7%-12.7%) per transfusion episode. All recipients of units with positive bacterial cultures were receiving antibiotics at the time of transfusion; none experienced a reaction. CONCLUSIONS: The rate of BC observed in this study is lower than previously reported in SSA, but still remains a safety issue. Because Gram staining appears to be an ineffective screening tool, alternate methods should be explored to prevent transfusing bacterially contaminated platelets in sub-Saharan Africa.
BACKGROUND: Little data are available on bacterial contamination (BC) of platelet units or acute transfusion reactions to platelet transfusions (PTs) in sub-Saharan Africa (SSA). STUDY DESIGN AND METHODS: This prospective, observational study evaluated the rate of BC in whole blood-derived platelet units (WB-PUs), the utility of performing Gram stains to prevent septic reactions, characteristics of patients receiving PTs, and the rate of acute reactions associated with PTs at the Uganda Cancer Institute in Kampala, Uganda. An aliquot of each WB-PU studied was taken to perform Gram stains and culture using the Bactec 9120 instrument. Study participants were monitored for reactions. RESULTS: In total, 337 WB-PUs were evaluated for BC, of which 323 units were transfused in 151 transfusion episodes to 50 patients. The frequency of BC ranged from 0.3% to 2.1% (according to criteria used to define BC). The Gram stain had high specificity (99.1%) but low sensitivity to detect units with BC. The median platelet count before PT was 10,900 cells/µL (interquartile range, 6000-18,900 cells/µL). Overall, 78% of PTs were given to patients with no bleeding. Acute reactions occurred in 11 transfusion episodes, involving 13 WB-PUs, for a rate of 7.3% (95% confidence interval, 3.7%-12.7%) per transfusion episode. All recipients of units with positive bacterial cultures were receiving antibiotics at the time of transfusion; none experienced a reaction. CONCLUSIONS: The rate of BC observed in this study is lower than previously reported in SSA, but still remains a safety issue. Because Gram staining appears to be an ineffective screening tool, alternate methods should be explored to prevent transfusing bacterially contaminated platelets in sub-Saharan Africa.
Authors: Aaron A R Tobian; William J Savage; Daniel J Tisch; Sandra Thoman; Karen E King; Paul M Ness Journal: Transfusion Date: 2011-01-07 Impact factor: 3.157
Authors: Ambuj Kumar; Rahul Mhaskar; Brenda J Grossman; Richard M Kaufman; Aaron A R Tobian; Steven Kleinman; Terry Gernsheimer; Alan T Tinmouth; Benjamin Djulbegovic Journal: Transfusion Date: 2014-11-12 Impact factor: 3.157
Authors: Benjamin P L Meza; Britta Lohrke; Robert Wilkinson; John P Pitman; Ray W Shiraishi; Naomi Bock; David W Lowrance; Matthew J Kuehnert; Mary Mataranyika; Sridhar V Basavaraju Journal: Blood Transfus Date: 2013-11-15 Impact factor: 3.443
Authors: Andrew Anthony Adjei; George Khumalo Kuma; Yao Tettey; Patrick Ferdinand Ayeh-Kumi; Japheth Opintan; Francis Apeagyei; Jacob Otinkorang Ankrah; Theophilus Korku Adiku; Edwin Gbli Narter-Olaga Journal: Jpn J Infect Dis Date: 2009-07 Impact factor: 1.362
Authors: Karen E King; R Sue Shirey; Sandra K Thoman; Debra Bensen-Kennedy; Warren S Tanz; Paul M Ness Journal: Transfusion Date: 2004-01 Impact factor: 3.157
Authors: Ronnie Kasirye; Heather A Hume; Evan M Bloch; Irene Lubega; Dorothy Kyeyune; Ruchee Shrestha; Henry Ddungu; Hellen Wambongo Musana; Aggrey Dhabangi; Joseph Ouma; Priscilla Eroju; Telsa de Lange; Michael Tartakovsky; Jodie L White; Ceasar Kakura; Mary Glenn Fowler; Philippa Musoke; Monica Nolan; M Kate Grabowski; Lawrence H Moulton; Susan L Stramer; Denise Whitby; Peter A Zimmerman; Deo Wabwire; Isaac Kajja; Jeffrey McCullough; Raymond Goodrich; Thomas C Quinn; Robert Cortes; Paul M Ness; Aaron A R Tobian Journal: Trials Date: 2022-04-04 Impact factor: 2.279
Authors: Clement D Okello; Andrew W Shih; Bridget Angucia; Noah Kiwanuka; Nancy Heddle; Jackson Orem; Harriet Mayanja-Kizza Journal: PLoS One Date: 2022-09-22 Impact factor: 3.752